US › Healthcare

Trinity Biotech plc (TRIB)

US · Healthcare · Medical Devices

$8.03+1.26%

Last close · 2026-10-16

Latest quarter · ended 2026-03-31

Revenue

$11.1M

Revenue YoY

-27.0%

Net profit

$-17.5M

EPS

$-28.12

Net margin

-157.8%

Key statistics

Market cap

$5.6M

Forward P/E

4.5

P/B

5.75

Book value

$-115.42

EPS (TTM)

$-60.00

52-week high

$52.50

52-week low

$5.01

50-day MA

$9.04

200-day MA

$16.73

Beta

0.97

Analyst view

with an average price target of $3.00.

Shareholding

Insiders

13.81%

Institutions

4.07%

Largest institutional holders

Fund	Stake
Hunter Associates Inc.	2.71%
Williams & Novak LLC	0.58%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.	0.18%
Susquehanna International Group, LLP	0.11%
Moss Adams Wealth Advisors LLC	0.11%
Integrys Wealth Advisors LLC	0.10%
Becker Capital	0.07%
LPL Financial Corp	0.07%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Trinity Biotech plc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.